DelveInsight’s, “ Idiopathic Pulmonary Fibrosis Pipeline Insights 2025 ” report provides comprehensive insights about 80+ ...

Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease characterised by the accumulation of scar ...

The study found through multi-omics integration analysis that rheumatoid arthritis is a causal factor of idiopathic pulmonary ...

Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a ...

Kristy Smith says in June she was diagnosed with idiopathic pulmonary fibrosis which caused scarring on the lungs and makes ...

In August 2025, InSilico Medicine Hong Kong Limited announced a clinical trial is to learn about INS018_055 in adults with ...

Contineum Therapeutics has pumped the brakes on two projects, freeing up resources to go full speed ahead in its pursuit of Bristol Myers Squibb in idiopathic pulmonary fibrosis.

With limited treatment options and potential for admission to the intensive care unit, researchers of a new paper highlighted ...

Christopher Kennedy didn't think anything was wrong. Soon, doctors were telling him a double lung transplant was his only option.

Discover Trevi Therapeutics' Q2 2025 progress, featuring groundbreaking CORAL & RIVER trial data, a $204M cash position, and plans for multiple Phase ...

Factors such as age, smoking status, and body mass index can help clinicians predict a patient’s risk of 30-day mortality.